Pheochromocytoma and Paraganglioma

Virtual assistant designed to support endocrinologists, oncologists, surgeons, internists, and primary care physicians in the diagnosis, treatment, and follow-up of pheochromocytoma and paraganglioma, based on the most recent scientific evidence (ENDO, NCCN, ESMO) and clinical guidelines valid as of July 2025.

Copied to clipboard

Content automatically generated by an artificial intelligence system.It may contain inaccuracies.